Penn Medicine and the Children\u2019s Hospital of Philadelphia\u2019s autism institute awarded its inaugural Nancy Lurie Marks Prize to a geneticist last week.<\/p>\n
The Lurie Autism Institute presented<\/a> its $100,000 award to Huda Zoghbi, a professor at the Baylor College of Medicine and the director of the Duncan Neurological Research Institute at Texas Children\u2019s Hospital. The prize is the institute\u2019s \u201chighest honor,\u201d and recognized Zoghbi for her discovery that variants of the MECP2 gene lead to Rett syndrome, a neurodevelopmental disorder related to autism.\u00a0<\/p>\n Zoghbi also demonstrated the role of \u201cde novo\u201d mutations \u2014 genetic variants not present in an individual\u2019s parents \u2014 in the syndrome.\u00a0<\/p>\n In a written statement to The Daily Pennsylvanian, Zoghbi described the motivations behind her work, citing the \u201cheart-wrenching\u201d prognosis of patients with Rett syndrome \u2014 who are almost<\/a> exclusively female.\u00a0<\/p>\n \u201cThese girls all started life healthy and socially interactive,\u201d she wrote. \u201cAnd then suddenly they become silent, withdrawn, and develop repetitive hand wringing.\u201d<\/p>\n Zoghbi also reflected on the challenges of early autism genetics research, noting that initial efforts focused primarily on familial cases.<\/p>\n \u201cWhen I was pursuing the gene that causes Rett syndrome, a sporadic disorder, the search for autism genes was focused on familial cases where there might be two or more children affected,\u201d Zoghbi wrote. \u201cSuch families were rare, thus, progress was slow.\u201d\u00a0<\/p>\n She explained that her team\u2019s discoveries helped show that \u201cperhaps one does not need families to find the genetic causes of autism.\u201d<\/p>\n The principles that Zoghbi established for autism research have since guided genomic studies of autism risk, including in frameworks adopted by the Simons Foundation Powering Autism Research for Knowledge and the Autism Sequencing Consortium.<\/p>\n Her \u201cbreakthrough transformed\u201d the syndrome \u201cfrom an enigmatic clinical condition into a foundational model for understanding autism genetics and neurobiology,\u201d according to Penn Medicine.<\/p>\n \u201cWe couldn\u2019t think of a more deserving inaugural recipient who exemplifies the pioneering work in autism research that the Lurie Autism Institute wants to make possible,\u201d Frances E. Jensen, co-chair of the prize selection committee, wrote in the release.\u00a0<\/p>\n Interim Director of the Lurie Autism Institute Daniel Rader similarly emphasized Zoghbi\u2019s \u201ccentral role in advancing\u201d the current understanding of neurobiology, and translating that \u201cbasic science\u201d into real clinical progress.<\/p>\n Zoghbi wrote to the DP that she hopes to use the prize to support initiatives that advance research and careers \u201cdedicated to solving neurodevelopmental disorders.\u201d <\/p>\n \u201cIt is critical that we invest in research that uncovers the root causes, and develop therapies that improve the lives of all those touched by these disorders,\u201d she wrote.\u00a0<\/p>\n Zoghbi will deliver a lecture at the 2026 Lurie Autism Institute Symposium on May 7, when she will be formally honored for the award.<\/p>\n She wrote to the DP that aspiring scientists today are \u201cextraordinarily lucky to be entering biomedical research at this moment in history.\u201d<\/p>\n \u201cThe barriers that once slowed discovery are falling away, one breakthrough at a time,\u201d she wrote. \u201cWe are living through a scientific renaissance, and you get to be part of it.\u201d<\/p>\n